These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


554 related items for PubMed ID: 15908948

  • 1. Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior.
    Goto Y, Grace AA.
    Nat Neurosci; 2005 Jun; 8(6):805-12. PubMed ID: 15908948
    [Abstract] [Full Text] [Related]

  • 2. Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core.
    Rouillon C, Abraini JH, David HN.
    Exp Neurol; 2008 Jul; 212(1):213-7. PubMed ID: 18501353
    [Abstract] [Full Text] [Related]

  • 3. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
    Rouillon C, Degoulet M, Chevallier K, Abraini JH, David HN.
    Brain Res; 2008 Mar 10; 1198():44-54. PubMed ID: 18261716
    [Abstract] [Full Text] [Related]

  • 4. Dopamine-dependent interactions between limbic and prefrontal cortical plasticity in the nucleus accumbens: disruption by cocaine sensitization.
    Goto Y, Grace AA.
    Neuron; 2005 Jul 21; 47(2):255-66. PubMed ID: 16039567
    [Abstract] [Full Text] [Related]

  • 5. Medial prefrontal cortical D1 receptor modulation of the meso-accumbens dopamine response to stress: an electrochemical study in freely-behaving rats.
    Doherty MD, Gratton A.
    Brain Res; 1996 Apr 09; 715(1-2):86-97. PubMed ID: 8739626
    [Abstract] [Full Text] [Related]

  • 6. Ventral striatal dopamine modulation of different forms of behavioral flexibility.
    Haluk DM, Floresco SB.
    Neuropsychopharmacology; 2009 Jul 09; 34(8):2041-52. PubMed ID: 19262467
    [Abstract] [Full Text] [Related]

  • 7. Early stress and chronic methylphenidate cross-sensitize dopaminergic responses in the adolescent medial prefrontal cortex and nucleus accumbens.
    Jezierski G, Zehle S, Bock J, Braun K, Gruss M.
    J Neurochem; 2007 Dec 09; 103(6):2234-44. PubMed ID: 17924950
    [Abstract] [Full Text] [Related]

  • 8. Dopamine activity in the nucleus accumbens modulates blocking in fear conditioning.
    Iordanova MD, Westbrook RF, Killcross AS.
    Eur J Neurosci; 2006 Dec 09; 24(11):3265-70. PubMed ID: 17156387
    [Abstract] [Full Text] [Related]

  • 9. Presynaptic D1 dopamine receptors facilitate glutamatergic neurotransmission in the rat globus pallidus.
    Hernández A, Sierra A, Valdiosera R, Florán B, Erlij D, Aceves J.
    Neurosci Lett; 2007 Oct 02; 425(3):188-91. PubMed ID: 17845833
    [Abstract] [Full Text] [Related]

  • 10. Decrease of lymphoproliferative response by amphetamine is mediated by dopamine from the nucleus accumbens: influence on splenic met-enkephalin levels.
    Assis MA, Valdomero A, García-Keller C, Sotomayor C, Cancela LM.
    Brain Behav Immun; 2011 May 02; 25(4):647-57. PubMed ID: 21237264
    [Abstract] [Full Text] [Related]

  • 11. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
    Rouillon C, Abraini JH, David HN.
    Hippocampus; 2007 May 02; 17(11):1028-36. PubMed ID: 17604350
    [Abstract] [Full Text] [Related]

  • 12. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
    Flores-Tochihuitl J, Vargas G, Morales-Medina JC, Rivera G, De La Cruz F, Zamudio S, Flores G.
    Synapse; 2008 Jan 02; 62(1):40-9. PubMed ID: 17957737
    [Abstract] [Full Text] [Related]

  • 13. Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens.
    MacDonald AF, Billington CJ, Levine AS.
    Brain Res; 2004 Aug 20; 1018(1):78-85. PubMed ID: 15262208
    [Abstract] [Full Text] [Related]

  • 14. Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors.
    Farrar AM, Segovia KN, Randall PA, Nunes EJ, Collins LE, Stopper CM, Port RG, Hockemeyer J, Müller CE, Correa M, Salamone JD.
    Neuroscience; 2010 Apr 14; 166(4):1056-67. PubMed ID: 20096336
    [Abstract] [Full Text] [Related]

  • 15. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell.
    Saurer TB, Carrigan KA, Ijames SG, Lysle DT.
    J Neuroimmunol; 2006 Apr 14; 173(1-2):3-11. PubMed ID: 16364456
    [Abstract] [Full Text] [Related]

  • 16. Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat.
    Schmidt HD, Pierce RC.
    Neuroscience; 2006 Oct 13; 142(2):451-61. PubMed ID: 16844308
    [Abstract] [Full Text] [Related]

  • 17. Stimulation by neurotensin of dopamine and 5-hydroxytryptamine (5-HT) release from rat prefrontal cortex: possible role of NTR1 receptors in neuropsychiatric disorders.
    Petkova-Kirova P, Rakovska A, Zaekova G, Ballini C, Corte LD, Radomirov R, Vágvölgyi A.
    Neurochem Int; 2008 Dec 13; 53(6-8):355-61. PubMed ID: 18835308
    [Abstract] [Full Text] [Related]

  • 18. Modulation of dopamine release by striatal 5-HT2C receptors.
    Alex KD, Yavanian GJ, McFarlane HG, Pluto CP, Pehek EA.
    Synapse; 2005 Mar 15; 55(4):242-51. PubMed ID: 15668911
    [Abstract] [Full Text] [Related]

  • 19. Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
    Pisanu A, Acquas E, Fenu S, Di Chiara G.
    Neuropharmacology; 2006 May 15; 50(6):661-70. PubMed ID: 16427098
    [Abstract] [Full Text] [Related]

  • 20. Prefrontal cortical D1 dopamine receptors modulate subcortical D2 dopamine receptor-mediated stress responsiveness.
    Scornaiencki R, Cantrup R, Rushlow WJ, Rajakumar N.
    Int J Neuropsychopharmacol; 2009 Oct 15; 12(9):1195-208. PubMed ID: 19275776
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.